APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-Infective Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti-Infective Vaccines Market Analysis and Forecast 2026-2032

Report ID 173965050221 December 2025209 pages

Choose your research edition.

Industry ResearchAnti-Infective Vaccines Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Infective Vaccines Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Anti-Infective Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Infective Vaccines Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Infective Vaccines Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Anti-Infective Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anti-Infective Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-Infective Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-Infective Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-Infective Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anti-Infective Vaccines include Sanofi Pasteur, Novartis Vaccines, Merck & Co., GlaxoSmithKline Biologicals, Wyeth Pharmaceuticals, Inc., Protein Sciences Co., Organon Teknika Co., MedImmune LLC and MassBiologics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anti-Infective Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-Infective Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-Infective Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-Infective Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-Infective Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti-Infective Vaccines sales, projected growth trends, production technology, application and end-user industry.

Anti-Infective Vaccines Segment by Company

Sanofi Pasteur

Novartis Vaccines

Merck & Co.

GlaxoSmithKline Biologicals

Wyeth Pharmaceuticals, Inc.

Protein Sciences Co.

Organon Teknika Co.

MedImmune LLC

MassBiologics

Intercell Biomedical

ID Biomedical Co.

Emergent BioDefense Operations Lansing Inc.

Diagnostics Ltd.

CSL Ltd.

Berna Biotech

Barr Labs, Inc.

Anti-Infective Vaccines Segment by Type

Inactivated Vaccines

Live/attenuated Vaccines

Conjugate Vaccines

Anti-Infective Vaccines Segment by Application

Bacterial Diseases

Viral Diseases

Anti-Infective Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infective Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Infective Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infective Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anti-Infective Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anti-Infective Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Infective Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-Infective Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Inactivated Vaccines Major Manufacturers Table 3. Live/attenuated Vaccines Major Manufacturers Table 4. Conjugate Vaccines Major Manufacturers Table 5. Global Anti-Infective Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Bacterial Diseases Major Manufacturers Table 7. Viral Diseases Major Manufacturers Table 8. Anti-Infective Vaccines Industry Trends Table 9. Anti-Infective Vaccines Industry Drivers Table 10. Anti-Infective Vaccines Industry Opportunities and Challenges Table 11. Anti-Infective Vaccines Industry Restraints Table 12. Global Anti-Infective Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Anti-Infective Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Anti-Infective Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Anti-Infective Vaccines Revenue Market Share by Region (2021-2026) Table 16. Global Anti-Infective Vaccines Revenue Market Share by Region (2027-2032) Table 17. Global Anti-Infective Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Anti-Infective Vaccines Sales by Region (2021-2026) & (k units) Table 19. Global Anti-Infective Vaccines Sales by Region (2027-2032) & (k units) Table 20. Global Anti-Infective Vaccines Sales Market Share by Region (2021-2026) Table 21. Global Anti-Infective Vaccines Sales Market Share by Region (2027-2032) Table 22. Global Anti-Infective Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Anti-Infective Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Anti-Infective Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2021-2026) Table 26. Global Anti-Infective Vaccines Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Anti-Infective Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Anti-Infective Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Anti-Infective Vaccines Manufacturers, Product Type & Application Table 30. Global Anti-Infective Vaccines Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Anti-Infective Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Anti-Infective Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Anti-Infective Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Anti-Infective Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Anti-Infective Vaccines Revenue Market Share by Type (2021-2026) Table 37. Global Anti-Infective Vaccines Revenue Market Share by Type (2027-2032) Table 38. Global Anti-Infective Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 40. Global Anti-Infective Vaccines Sales by Type (2027-2032) & (k units) Table 41. Global Anti-Infective Vaccines Sales Market Share by Type (2021-2026) Table 42. Global Anti-Infective Vaccines Sales Market Share by Type (2027-2032) Table 43. Global Anti-Infective Vaccines Price by Type (2021-2026) & (US$/unit) Table 44. Global Anti-Infective Vaccines Price by Type (2027-2032) & (US$/unit) Table 45. Global Anti-Infective Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Anti-Infective Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Anti-Infective Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Anti-Infective Vaccines Revenue Market Share by Application (2021-2026) Table 49. Global Anti-Infective Vaccines Revenue Market Share by Application (2027-2032) Table 50. Global Anti-Infective Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 52. Global Anti-Infective Vaccines Sales by Application (2027-2032) & (k units) Table 53. Global Anti-Infective Vaccines Sales Market Share by Application (2021-2026) Table 54. Global Anti-Infective Vaccines Sales Market Share by Application (2027-2032) Table 55. Global Anti-Infective Vaccines Price by Application (2021-2026) & (US$/unit) Table 56. Global Anti-Infective Vaccines Price by Application (2027-2032) & (US$/unit) Table 57. Sanofi Pasteur Company Information Table 58. Sanofi Pasteur Business Overview Table 59. Sanofi Pasteur Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Sanofi Pasteur Anti-Infective Vaccines Product Portfolio Table 61. Sanofi Pasteur Recent Development Table 62. Novartis Vaccines Company Information Table 63. Novartis Vaccines Business Overview Table 64. Novartis Vaccines Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Novartis Vaccines Anti-Infective Vaccines Product Portfolio Table 66. Novartis Vaccines Recent Development Table 67. Merck & Co. Company Information Table 68. Merck & Co. Business Overview Table 69. Merck & Co. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Merck & Co. Anti-Infective Vaccines Product Portfolio Table 71. Merck & Co. Recent Development Table 72. GlaxoSmithKline Biologicals Company Information Table 73. GlaxoSmithKline Biologicals Business Overview Table 74. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolio Table 76. GlaxoSmithKline Biologicals Recent Development Table 77. Wyeth Pharmaceuticals, Inc. Company Information Table 78. Wyeth Pharmaceuticals, Inc. Business Overview Table 79. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolio Table 81. Wyeth Pharmaceuticals, Inc. Recent Development Table 82. Protein Sciences Co. Company Information Table 83. Protein Sciences Co. Business Overview Table 84. Protein Sciences Co. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Protein Sciences Co. Anti-Infective Vaccines Product Portfolio Table 86. Protein Sciences Co. Recent Development Table 87. Organon Teknika Co. Company Information Table 88. Organon Teknika Co. Business Overview Table 89. Organon Teknika Co. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Organon Teknika Co. Anti-Infective Vaccines Product Portfolio Table 91. Organon Teknika Co. Recent Development Table 92. MedImmune LLC Company Information Table 93. MedImmune LLC Business Overview Table 94. MedImmune LLC Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. MedImmune LLC Anti-Infective Vaccines Product Portfolio Table 96. MedImmune LLC Recent Development Table 97. MassBiologics Company Information Table 98. MassBiologics Business Overview Table 99. MassBiologics Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. MassBiologics Anti-Infective Vaccines Product Portfolio Table 101. MassBiologics Recent Development Table 102. Intercell Biomedical Company Information Table 103. Intercell Biomedical Business Overview Table 104. Intercell Biomedical Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Intercell Biomedical Anti-Infective Vaccines Product Portfolio Table 106. Intercell Biomedical Recent Development Table 107. ID Biomedical Co. Company Information Table 108. ID Biomedical Co. Business Overview Table 109. ID Biomedical Co. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. ID Biomedical Co. Anti-Infective Vaccines Product Portfolio Table 111. ID Biomedical Co. Recent Development Table 112. Emergent BioDefense Operations Lansing Inc. Company Information Table 113. Emergent BioDefense Operations Lansing Inc. Business Overview Table 114. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolio Table 116. Emergent BioDefense Operations Lansing Inc. Recent Development Table 117. Diagnostics Ltd. Company Information Table 118. Diagnostics Ltd. Business Overview Table 119. Diagnostics Ltd. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Diagnostics Ltd. Anti-Infective Vaccines Product Portfolio Table 121. Diagnostics Ltd. Recent Development Table 122. CSL Ltd. Company Information Table 123. CSL Ltd. Business Overview Table 124. CSL Ltd. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. CSL Ltd. Anti-Infective Vaccines Product Portfolio Table 126. CSL Ltd. Recent Development Table 127. Berna Biotech Company Information Table 128. Berna Biotech Business Overview Table 129. Berna Biotech Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Berna Biotech Anti-Infective Vaccines Product Portfolio Table 131. Berna Biotech Recent Development Table 132. Barr Labs, Inc. Company Information Table 133. Barr Labs, Inc. Business Overview Table 134. Barr Labs, Inc. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Barr Labs, Inc. Anti-Infective Vaccines Product Portfolio Table 136. Barr Labs, Inc. Recent Development Table 137. North America Anti-Infective Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 138. North America Anti-Infective Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 139. North America Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 140. North America Anti-Infective Vaccines Sales by Type (2027-2032) & (k units) Table 141. North America Anti-Infective Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 142. North America Anti-Infective Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 143. North America Anti-Infective Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 144. North America Anti-Infective Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 145. North America Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 146. North America Anti-Infective Vaccines Sales by Application (2027-2032) & (k units) Table 147. North America Anti-Infective Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 148. North America Anti-Infective Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 149. North America Anti-Infective Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. North America Anti-Infective Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. North America Anti-Infective Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. North America Anti-Infective Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 153. North America Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 154. North America Anti-Infective Vaccines Sales by Country (2027-2032) & (k units) Table 155. North America Anti-Infective Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 156. North America Anti-Infective Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 157. United States Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 158. Canada Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 159. Mexico Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 160. Europe Anti-Infective Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 161. Europe Anti-Infective Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 162. Europe Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 163. Europe Anti-Infective Vaccines Sales by Type (2027-2032) & (k units) Table 164. Europe Anti-Infective Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 165. Europe Anti-Infective Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 166. Europe Anti-Infective Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 167. Europe Anti-Infective Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 168. Europe Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 169. Europe Anti-Infective Vaccines Sales by Application (2027-2032) & (k units) Table 170. Europe Anti-Infective Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 171. Europe Anti-Infective Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 172. Europe Anti-Infective Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Europe Anti-Infective Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Europe Anti-Infective Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Europe Anti-Infective Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 176. Europe Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 177. Europe Anti-Infective Vaccines Sales by Country (2027-2032) & (k units) Table 178. Europe Anti-Infective Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 179. Europe Anti-Infective Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 180. Germany Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 181. France Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 182. U.K. Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 183. Italy Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 184. Russia Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 185. Spain Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 186. Netherlands Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 187. Switzerland Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 188. Sweden Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 189. Poland Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 190. China Anti-Infective Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 191. China Anti-Infective Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 192. China Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 193. China Anti-Infective Vaccines Sales by Type (2027-2032) & (k units) Table 194. China Anti-Infective Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 195. China Anti-Infective Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 196. China Anti-Infective Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 197. China Anti-Infective Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 198. China Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 199. China Anti-Infective Vaccines Sales by Application (2027-2032) & (k units) Table 200. China Anti-Infective Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 201. China Anti-Infective Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 202. Asia Anti-Infective Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 203. Asia Anti-Infective Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 204. Asia Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 205. Asia Anti-Infective Vaccines Sales by Type (2027-2032) & (k units) Table 206. Asia Anti-Infective Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 207. Asia Anti-Infective Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 208. Asia Anti-Infective Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 209. Asia Anti-Infective Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 210. Asia Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 211. Asia Anti-Infective Vaccines Sales by Application (2027-2032) & (k units) Table 212. Asia Anti-Infective Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 213. Asia Anti-Infective Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 214. Asia Anti-Infective Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Asia Anti-Infective Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. Asia Anti-Infective Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. Asia Anti-Infective Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 218. Asia Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 219. Asia Anti-Infective Vaccines Sales by Country (2027-2032) & (k units) Table 220. Asia Anti-Infective Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 221. Asia Anti-Infective Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 222. Japan Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 223. South Korea Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 224. India Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 225. Australia Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 226. Taiwan Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 227. Southeast Asia Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 228. SAMEA Anti-Infective Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 229. SAMEA Anti-Infective Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 230. SAMEA Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 231. SAMEA Anti-Infective Vaccines Sales by Type (2027-2032) & (k units) Table 232. SAMEA Anti-Infective Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 233. SAMEA Anti-Infective Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 234. SAMEA Anti-Infective Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 235. SAMEA Anti-Infective Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 236. SAMEA Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 237. SAMEA Anti-Infective Vaccines Sales by Application (2027-2032) & (k units) Table 238. SAMEA Anti-Infective Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 239. SAMEA Anti-Infective Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 240. SAMEA Anti-Infective Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. SAMEA Anti-Infective Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. SAMEA Anti-Infective Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. SAMEA Anti-Infective Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 244. SAMEA Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 245. SAMEA Anti-Infective Vaccines Sales by Country (2027-2032) & (k units) Table 246. SAMEA Anti-Infective Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 247. SAMEA Anti-Infective Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 248. Brazil Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 249. Argentina Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 250. Chile Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 251. Colombia Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 252. Peru Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 253. Saudi Arabia Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 254. Israel Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 255. UAE Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 256. Turkey Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 257. Iran Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 258. Egypt Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Table 259. Key Raw Materials Table 260. Raw Materials Key Suppliers Table 261. Anti-Infective Vaccines Distributors List Table 262. Anti-Infective Vaccines Customers List Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources Table 266. Primary Sources List of Figures Figure 1. Anti-Infective Vaccines Image Figure 2. Global Anti-Infective Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Infective Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Inactivated Vaccines Image Figure 5. Live/attenuated Vaccines Image Figure 6. Conjugate Vaccines Image Figure 7. Global Anti-Infective Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Anti-Infective Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 9. Bacterial Diseases Image Figure 10. Viral Diseases Image Figure 11. Global Anti-Infective Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Figure 13. Global Anti-Infective Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Anti-Infective Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Anti-Infective Vaccines Revenue Market Share by Region (2021-2032) Figure 16. Global Anti-Infective Vaccines Sales (2021-2032) & (k units) Figure 17. Global Anti-Infective Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Anti-Infective Vaccines Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Anti-Infective Vaccines Sales YoY (2021-2032) & (k units) Figure 20. Europe Anti-Infective Vaccines Sales YoY (2021-2032) & (k units) Figure 21. China Anti-Infective Vaccines Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Anti-Infective Vaccines Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Anti-Infective Vaccines Sales YoY (2021-2032) & (k units) Figure 24. Global Anti-Infective Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Anti-Infective Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Anti-Infective Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Anti-Infective Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Anti-Infective Vaccines Revenue Market Share by Type (2021-2032) Figure 30. Global Anti-Infective Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Anti-Infective Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Anti-Infective Vaccines Sales Market Share by Type (2021-2032) Figure 33. Global Anti-Infective Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Anti-Infective Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Anti-Infective Vaccines Revenue Market Share by Application (2021-2032) Figure 36. Global Anti-Infective Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Anti-Infective Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Anti-Infective Vaccines Sales Market Share by Application (2021-2032) Figure 39. North America Anti-Infective Vaccines Revenue Share by Type (2021-2032) Figure 40. North America Anti-Infective Vaccines Sales Share by Type (2021-2032) Figure 41. North America Anti-Infective Vaccines Revenue Share by Application (2021-2032) Figure 42. North America Anti-Infective Vaccines Sales Share by Application (2021-2032) Figure 43. North America Anti-Infective Vaccines Revenue Share by Country (2021-2032) Figure 44. North America Anti-Infective Vaccines Sales Share by Country (2021-2032) Figure 45. Europe Anti-Infective Vaccines Revenue Share by Type (2021-2032) Figure 46. Europe Anti-Infective Vaccines Sales Share by Type (2021-2032) Figure 47. Europe Anti-Infective Vaccines Revenue Share by Application (2021-2032) Figure 48. Europe Anti-Infective Vaccines Sales Share by Application (2021-2032) Figure 49. Europe Anti-Infective Vaccines Revenue Share by Country (2021-2032) Figure 50. Europe Anti-Infective Vaccines Sales Share by Country (2021-2032) Figure 51. China Anti-Infective Vaccines Revenue Share by Type (2021-2032) Figure 52. China Anti-Infective Vaccines Sales Share by Type (2021-2032) Figure 53. China Anti-Infective Vaccines Revenue Share by Application (2021-2032) Figure 54. China Anti-Infective Vaccines Sales Share by Application (2021-2032) Figure 55. Asia Anti-Infective Vaccines Revenue Share by Type (2021-2032) Figure 56. Asia Anti-Infective Vaccines Sales Share by Type (2021-2032) Figure 57. Asia Anti-Infective Vaccines Revenue Share by Application (2021-2032) Figure 58. Asia Anti-Infective Vaccines Sales Share by Application (2021-2032) Figure 59. Asia Anti-Infective Vaccines Revenue Share by Country (2021-2032) Figure 60. Asia Anti-Infective Vaccines Sales Share by Country (2021-2032) Figure 61. SAMEA Anti-Infective Vaccines Revenue Share by Type (2021-2032) Figure 62. SAMEA Anti-Infective Vaccines Sales Share by Type (2021-2032) Figure 63. SAMEA Anti-Infective Vaccines Revenue Share by Application (2021-2032) Figure 64. SAMEA Anti-Infective Vaccines Sales Share by Application (2021-2032) Figure 65. SAMEA Anti-Infective Vaccines Revenue Share by Country (2021-2032) Figure 66. SAMEA Anti-Infective Vaccines Sales Share by Country (2021-2032) Figure 67. Anti-Infective Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Anti-Infective Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccines
  • Live/attenuated Vaccines
  • Conjugate Vaccines
Applications
  • Bacterial Diseases
  • Viral Diseases
Companies covered
  • Sanofi Pasteur
  • Novartis Vaccines
  • Merck & Co.
  • GlaxoSmithKline Biologicals
  • Wyeth Pharmaceuticals, Inc.
  • Protein Sciences Co.
  • Organon Teknika Co.
  • MedImmune LLC
  • MassBiologics
  • Intercell Biomedical
  • ID Biomedical Co.
  • Emergent BioDefense Operations Lansing Inc.
  • Diagnostics Ltd.
  • CSL Ltd.
  • Berna Biotech
  • Barr Labs, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-Infective Vaccines Market by Type
  3. 1.2.1 Global Anti-Infective Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Inactivated Vaccines
  5. 1.2.3 Live/attenuated Vaccines
  6. 1.2.4 Conjugate Vaccines
  7. 1.3 Anti-Infective Vaccines Market by Application
  8. 1.3.1 Global Anti-Infective Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Bacterial Diseases
  10. 1.3.3 Viral Diseases
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Anti-Infective Vaccines Market Dynamics
  1. 2.1 Anti-Infective Vaccines Industry Trends
  2. 2.2 Anti-Infective Vaccines Industry Drivers
  3. 2.3 Anti-Infective Vaccines Industry Opportunities and Challenges
  4. 2.4 Anti-Infective Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anti-Infective Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anti-Infective Vaccines Revenue by Region
  3. 3.2.1 Global Anti-Infective Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-Infective Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Anti-Infective Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Anti-Infective Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anti-Infective Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anti-Infective Vaccines Sales by Region
  9. 3.4.1 Global Anti-Infective Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anti-Infective Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Anti-Infective Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Anti-Infective Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anti-Infective Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Anti-Infective Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anti-Infective Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anti-Infective Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-Infective Vaccines Sales by Manufacturers
  6. 4.2.1 Global Anti-Infective Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anti-Infective Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anti-Infective Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anti-Infective Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anti-Infective Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anti-Infective Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Anti-Infective Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anti-Infective Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Anti-Infective Vaccines Tier 1, Tier 2, and Tier 3
5 Anti-Infective Vaccines Market by Type
  1. 5.1 Global Anti-Infective Vaccines Revenue by Type
  2. 5.1.1 Global Anti-Infective Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anti-Infective Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anti-Infective Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anti-Infective Vaccines Sales by Type
  6. 5.2.1 Global Anti-Infective Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-Infective Vaccines Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Anti-Infective Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anti-Infective Vaccines Price by Type
6 Anti-Infective Vaccines Market by Application
  1. 6.1 Global Anti-Infective Vaccines Revenue by Application
  2. 6.1.1 Global Anti-Infective Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anti-Infective Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anti-Infective Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anti-Infective Vaccines Sales by Application
  6. 6.2.1 Global Anti-Infective Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anti-Infective Vaccines Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Anti-Infective Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anti-Infective Vaccines Price by Application
7 Company Profiles
  1. 7.1 Sanofi Pasteur
  2. 7.1.1 Sanofi Pasteur Company Information
  3. 7.1.2 Sanofi Pasteur Business Overview
  4. 7.1.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Pasteur Anti-Infective Vaccines Product Portfolio
  6. 7.1.5 Sanofi Pasteur Recent Developments
  7. 7.2 Novartis Vaccines
  8. 7.2.1 Novartis Vaccines Company Information
  9. 7.2.2 Novartis Vaccines Business Overview
  10. 7.2.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Vaccines Anti-Infective Vaccines Product Portfolio
  12. 7.2.5 Novartis Vaccines Recent Developments
  13. 7.3 Merck & Co.
  14. 7.3.1 Merck & Co. Company Information
  15. 7.3.2 Merck & Co. Business Overview
  16. 7.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck & Co. Anti-Infective Vaccines Product Portfolio
  18. 7.3.5 Merck & Co. Recent Developments
  19. 7.4 GlaxoSmithKline Biologicals
  20. 7.4.1 GlaxoSmithKline Biologicals Company Information
  21. 7.4.2 GlaxoSmithKline Biologicals Business Overview
  22. 7.4.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolio
  24. 7.4.5 GlaxoSmithKline Biologicals Recent Developments
  25. 7.5 Wyeth Pharmaceuticals, Inc.
  26. 7.5.1 Wyeth Pharmaceuticals, Inc. Company Information
  27. 7.5.2 Wyeth Pharmaceuticals, Inc. Business Overview
  28. 7.5.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolio
  30. 7.5.5 Wyeth Pharmaceuticals, Inc. Recent Developments
  31. 7.6 Protein Sciences Co.
  32. 7.6.1 Protein Sciences Co. Company Information
  33. 7.6.2 Protein Sciences Co. Business Overview
  34. 7.6.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Protein Sciences Co. Anti-Infective Vaccines Product Portfolio
  36. 7.6.5 Protein Sciences Co. Recent Developments
  37. 7.7 Organon Teknika Co.
  38. 7.7.1 Organon Teknika Co. Company Information
  39. 7.7.2 Organon Teknika Co. Business Overview
  40. 7.7.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Organon Teknika Co. Anti-Infective Vaccines Product Portfolio
  42. 7.7.5 Organon Teknika Co. Recent Developments
  43. 7.8 MedImmune LLC
  44. 7.8.1 MedImmune LLC Company Information
  45. 7.8.2 MedImmune LLC Business Overview
  46. 7.8.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 MedImmune LLC Anti-Infective Vaccines Product Portfolio
  48. 7.8.5 MedImmune LLC Recent Developments
  49. 7.9 MassBiologics
  50. 7.9.1 MassBiologics Company Information
  51. 7.9.2 MassBiologics Business Overview
  52. 7.9.3 MassBiologics Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 MassBiologics Anti-Infective Vaccines Product Portfolio
  54. 7.9.5 MassBiologics Recent Developments
  55. 7.10 Intercell Biomedical
  56. 7.10.1 Intercell Biomedical Company Information
  57. 7.10.2 Intercell Biomedical Business Overview
  58. 7.10.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Intercell Biomedical Anti-Infective Vaccines Product Portfolio
  60. 7.10.5 Intercell Biomedical Recent Developments
  61. 7.11 ID Biomedical Co.
  62. 7.11.1 ID Biomedical Co. Company Information
  63. 7.11.2 ID Biomedical Co. Business Overview
  64. 7.11.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 ID Biomedical Co. Anti-Infective Vaccines Product Portfolio
  66. 7.11.5 ID Biomedical Co. Recent Developments
  67. 7.12 Emergent BioDefense Operations Lansing Inc.
  68. 7.12.1 Emergent BioDefense Operations Lansing Inc. Company Information
  69. 7.12.2 Emergent BioDefense Operations Lansing Inc. Business Overview
  70. 7.12.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolio
  72. 7.12.5 Emergent BioDefense Operations Lansing Inc. Recent Developments
  73. 7.13 Diagnostics Ltd.
  74. 7.13.1 Diagnostics Ltd. Company Information
  75. 7.13.2 Diagnostics Ltd. Business Overview
  76. 7.13.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Diagnostics Ltd. Anti-Infective Vaccines Product Portfolio
  78. 7.13.5 Diagnostics Ltd. Recent Developments
  79. 7.14 CSL Ltd.
  80. 7.14.1 CSL Ltd. Company Information
  81. 7.14.2 CSL Ltd. Business Overview
  82. 7.14.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 CSL Ltd. Anti-Infective Vaccines Product Portfolio
  84. 7.14.5 CSL Ltd. Recent Developments
  85. 7.15 Berna Biotech
  86. 7.15.1 Berna Biotech Company Information
  87. 7.15.2 Berna Biotech Business Overview
  88. 7.15.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Berna Biotech Anti-Infective Vaccines Product Portfolio
  90. 7.15.5 Berna Biotech Recent Developments
  91. 7.16 Barr Labs, Inc.
  92. 7.16.1 Barr Labs, Inc. Company Information
  93. 7.16.2 Barr Labs, Inc. Business Overview
  94. 7.16.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Barr Labs, Inc. Anti-Infective Vaccines Product Portfolio
  96. 7.16.5 Barr Labs, Inc. Recent Developments
8 North America
  1. 8.1 North America Anti-Infective Vaccines Market Size by Type
  2. 8.1.1 North America Anti-Infective Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Anti-Infective Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Anti-Infective Vaccines Price by Type (2021-2032)
  5. 8.2 North America Anti-Infective Vaccines Market Size by Application
  6. 8.2.1 North America Anti-Infective Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Anti-Infective Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Anti-Infective Vaccines Price by Application (2021-2032)
  9. 8.3 North America Anti-Infective Vaccines Market Size by Country
  10. 8.3.1 North America Anti-Infective Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anti-Infective Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anti-Infective Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Anti-Infective Vaccines Market Size by Type
  2. 9.1.1 Europe Anti-Infective Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anti-Infective Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Anti-Infective Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Anti-Infective Vaccines Market Size by Application
  6. 9.2.1 Europe Anti-Infective Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anti-Infective Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Anti-Infective Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Anti-Infective Vaccines Market Size by Country
  10. 9.3.1 Europe Anti-Infective Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anti-Infective Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anti-Infective Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Anti-Infective Vaccines Market Size by Type
  2. 10.1.1 China Anti-Infective Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Anti-Infective Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Anti-Infective Vaccines Price by Type (2021-2032)
  5. 10.2 China Anti-Infective Vaccines Market Size by Application
  6. 10.2.1 China Anti-Infective Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Anti-Infective Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Anti-Infective Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-Infective Vaccines Market Size by Type
  2. 11.1.1 Asia Anti-Infective Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anti-Infective Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Anti-Infective Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Anti-Infective Vaccines Market Size by Application
  6. 11.2.1 Asia Anti-Infective Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anti-Infective Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Anti-Infective Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Anti-Infective Vaccines Market Size by Country
  10. 11.3.1 Asia Anti-Infective Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anti-Infective Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anti-Infective Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-Infective Vaccines Market Size by Type
  2. 12.1.1 SAMEA Anti-Infective Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anti-Infective Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anti-Infective Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Anti-Infective Vaccines Market Size by Application
  6. 12.2.1 SAMEA Anti-Infective Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anti-Infective Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anti-Infective Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Anti-Infective Vaccines Market Size by Country
  10. 12.3.1 SAMEA Anti-Infective Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anti-Infective Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anti-Infective Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anti-Infective Vaccines Value Chain Analysis
  2. 13.1.1 Anti-Infective Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anti-Infective Vaccines Production Mode & Process
  6. 13.2 Anti-Infective Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anti-Infective Vaccines Distributors
  9. 13.2.3 Anti-Infective Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst